Calcium-signaling components in rat insulinoma β-cells (INS-1) and pancreatic islets are differentially influenced by melatonin

Journal of Pineal Research

Volumn 56, Issue 4, 2014, Pages 439-449

  Bazwinsky Wutschke, Ivonne ^a   Mühlbauer, Eckhard ^b   Albrecht, Elke ^a   Peschke, Elmar ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Saxon Academy of Sciences   (Germany)

Author keywords

Camk2d; CamkIV; melatonin; melatonin receptor; melatonin receptor knockout mouse; pancreatic cell

Indexed keywords

CALCIUM CALMODULIN DEPENDENT KINASE 2D; CALCIUM CALMODULIN DEPENDENT KINASE IV; CALMODULIN; CALMODULIN 1; FORSKOLIN; INSULIN; ISOBUTYLMETHYLXANTHINE; MELATONIN; MELATONIN RECEPTOR; UNCLASSIFIED DRUG; ANTIOXIDANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INSULINOMA; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; ANIMAL; DRUG EFFECTS; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; PATHOLOGY; RAT; TUMOR CELL LINE;

ANIMALS; ANTIOXIDANTS; BASE SEQUENCE; CALCIUM SIGNALING; CELL LINE, TUMOR; HUMANS; INSULINOMA; MELATONIN; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; RATS;

EID: 84899453869     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12135     Document Type: Article

References (50)

1. Peschke E, Mühlbauer E, Musshoff U, et al. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 2002; 33: 63-71.
2. Peschke E, Bach AG, Mühlbauer E,. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res 2006; 40: 184-191.
3. Peschke E, Mühlbauer E,. New evidence for a role of melatonin in glucose regulation. Best Pract Res Clin Endocrinol Metab 2010; 24: 829-841.
4. Peschk E, Bähr I, Mühlbauer E,. Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon. Int J Mol Sci 2013; 14: 6981-7015.
5. Mühlbauer E, Albrecht E, Bazwinsky-Wutschke I, et al. Melatonin influences insulin secretion primarily via MT(1) receptors in rat insulinoma cells (INS-1) and mouse pancreatic islets. J Pineal Res 2012; 52: 446-459.
6. Bazwinsky-Wutschke I, Mühlbauer E, Wolgast S, et al. Transcripts of calcium/calmodulin-dependent kinases are changed after forskolin- or IBMX-induced insulin secretion due to melatonin treatment of rat insulinoma beta-cells (INS-1). Horm Metab Res 2009; 41: 805-813.
7. Bazwinsky-Wutschke I, Wolgast S, Mühlbauer E, et al. Phosphorylation of cyclic AMP-response element-binding protein (CREB) is influenced by melatonin treatment in pancreatic rat insulinoma β-cells (INS-1). J Pineal Res 2012; 53: 344-357.
8. (2+)/calmodulin-dependent protein kinases. Cell Mol Life Sci 2008; 65: 2637-2657.
9. 2+/calmodulin-dependent protein kinase II delta2 regulates gene expression of insulin in INS-1 rat insulinoma cells. Cell Calcium 2003; 33: 175-184.
10. Easom RA,. CaM kinase II: a protein kinase with extraordinary talents germane to insulin exocytosis. Diabetes 1999; 48: 675-684.
11. 2+/calmodulin-dependent phosphorylation of synapsin I in insulin exocytosis. J Pharmacol Sci 2003; 93: 30-34.
12. Yu X, Murao K, Sayo Y, et al. The role of calcium/calmodulin-dependent protein kinase cascade in glucose upregulation of insulin gene expression. Diabetes 2004; 53: 1475-1481.
13. Persaud SJ, Liu B, Sampaio HB, et al. Calcium/calmodulin-dependent kinase IV controls glucose-induced Irs2 expression in mouse beta cells via activation of cAMP response element-binding protein. Diabetologia 2011; 54: 1109-1120.
14. Sugden MC, Christie MR, Ashcroft SJ,. Presence and possible role of calcium-dependent regulator (calmodulin) in rat islets of Langerhans. FEBS Lett 1979; 105: 95-100.
15. Bazwinsky-Wutschke I, Wolgast S, Mühlbauer E, et al. Distribution patterns of calcium-binding proteins in pancreatic tissue of non-diabetic as well as type 2 diabetic rats and in rat insulinoma beta-cells (INS-1). Histochem Cell Biol 2010; 134: 115-127.
16. Bazwinsky-Wutschke I, Bieseke L, Mühlbauer E, et al. Influence of melatonin receptor signalling on parameters involved in blood glucose regulation. J Pineal Res 2014; 56: 82-96.
17. Mühlbauer E, Wolgast S, Finckh U, et al. Indication of circadian oscillations in the rat pancreas. FEBS Lett 2004; 564: 91-96.
18. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25: 402-408.
19. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
20. Radonic A, Thulke S, Mackay IM, et al. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004; 313: 856-862.
21. Touchberry CD, Wacker MJ, Richmond SR, et al. Age-related changes in relative expression of real-time PCR housekeeping genes in human skeletal muscle. J Biomol Tech 2006; 17: 157-162.
22. Mühlbauer E, Albrecht E, Hofmann K, et al. Melatonin inhibits insulin secretion in rat insulinoma β-cells (INS-1) heterologously expressing the human melatonin receptor isoform MT2. J Pineal Res 2011; 51: 361-372.
23. Seino S, Takahashi H, Fujimoto W, et al. Roles of cAMP signalling in insulin granule exocytosis. Diabetes Obes Metab 2009; 11: 180-188.
24. Furman B, Ong WK, Pyne NJ,. Cyclic AMP signaling in pancreatic islets. Adv Exp Med Biol 2010; 654: 281-304.
25. Asfari M, Janjic D, Meda P, et al. Establishment of 2-mercaptoethanol- dependent differentiated insulin-secreting cell lines. Endocrinology 1992; 130: 167-178.
26. Reppert SM, Godson C, Mahle CD, et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A. 1995; 92: 8734-8738.
27. Mackenzie RS, Melan MA, Passey DK, et al. Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure. Biochem Pharmacol 2002; 63: 587-595.
28. 2+/calmodulin-dependent kinase II activity by melatonin. Biochim Biophys Acta 1996; 1290: 191-196.
29. Antón-Tay F, Forray C, Ortega-Corona BG,. Subneuronal fate of intracerebro-ventricular injected 3H-melatonin. J Pineal Res 1988; 5: 125-133.
30. Benítez-King G, Antón-Tay F,. Calmodulin mediates melatonin cytoskeletal effects. Experientia 1993; 49: 635-641.
31. Benítez-King G, Huerto-Delgadillo L, Antón-Tay F,. Binding of 3H-melatonin to calmodulin. Life Sci 1993; 53: 201-207.
32. Matsumoto K, Ebihara K, Yamamoto H, et al. Cloning from insulinoma cells of synapsin I associated with insulin secretory granules. J Biol Chem 1999; 274: 2053-2059.
33. 2+/calmodulin-dependent protein kinase II in isolated rat pancreatic islets. J Biol Chem 1994; 269: 4947-4952.
34. 2+/calmodulin- dependent kinase II. J Biol Chem 1997; 272: 27464-27469.
35. Nielander HB, Onofri F, Valtorta F, et al. Phosphorylation of VAMP/synaptobrevin in synaptic vesicles by endogenous protein kinases. J Neurochem 1995; 65: 1712-1720.
36. Hirling H, Scheller RH,. Phosphorylation of synaptic vesicle proteins: modulation of the alpha SNAP interaction with the core complex. Proc Natl Acad Sci U S A 1996; 93: 11945-11949.
37. Verona M, Zanotti S, Schäfer T, et al. Changes of synaptotagmin interaction with t-SNARE proteins in vitro after calcium/calmodulin-dependent phosphorylation. J Neurochem 2000; 74: 209-221.
38. 2+/calmodulin protein kinase II in synaptic vesicles. FEBS Lett 1993; 317: 85-88.
39. Valtorta F, Benfenati F, Greengard P,. Structure and function of the synapsins. J Biol Chem 1992; 267: 7195-7198.
40. 2+/calmodulin-dependent protein kinase II delta associated with insulin secretion vesicles. Endocrinology 1997; 138: 2577-2584.
41. 2+/calmodulin-dependent protein kinase II in insulinoma MIN6 cells. Endocrinology 2000; 141: 2350-2360.
42. 2+/calmodulin-dependent protein kinase II with the initiation of insulin secretion from perifused pancreatic islets. Endocrinology 1997; 138: 2359-2364.
43. (2+)/calmodulin-dependent protein kinase II. A re-evaluation of inhibitor studies. Biochem Pharmacol 2000; 60: 1655-1663.
44. Vest RS, Davies KD, O'leary H, et al. Dual mechanism of a natural CaMKII inhibitor. Mol Biol Cell 2007; 18: 5024-5033.
45. Kato I, Oya T, Suzuki H, et al. A novel model of insulin-dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIalpha (Thr286Asp) in pancreatic beta-cells. Diabetes Metab Res Rev 2008; 24: 486-497.
46. Dixit SS, Wang T, Manzano EJ, et al. Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance. PLoS One 2013; 8: e58655.
47. 2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J Biol Chem 1994; 269: 15520-15527.
48. Redmond L, Kashani AH, Gosh A,. Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription. Neuron 2002; 34: 999-1010.
49. 2+/calmodulin- dependent protein kinase type IV/Gr-deficient mice. J Neurosci 2000; 20: 6459-6472.
50. Stumpf I, Bazwinsky I, Peschke E,. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells. J Pineal Res 2009; 46: 140-147.